Cargando…

Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells

BACKGROUND: Interleukin (IL)-34 acts as an alternative ligand for the colony-stimulating factor-1 receptor and controls the biology of myeloid cells, including survival, proliferation, and differentiation. IL-34 has been reported to be expressed in cancer cells and to promote tumor progression and m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Nanumi, Anwar, Delnur, Hama, Naoki, Kobayashi, Takuto, Suzuki, Hidefumi, Takahashi, Hidehisa, Wada, Haruka, Otsuka, Ryo, Baghdadi, Muhammad, Seino, Ken-ichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556959/ https://www.ncbi.nlm.nih.gov/pubmed/33072227 http://dx.doi.org/10.1186/s41232-020-00129-4

Ejemplares similares

Interleukin-34 cancels anti-tumor immunity by PARP inhibitor
por: Nakamura, Takayoshi, et al.
Publicado: (2022)

Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
por: Hama, Naoki, et al.
Publicado: (2020)

Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
por: Hama, Naoki, et al.
Publicado: (2022)

An optimized protocol for patient-derived xenograft in humanized mice to evaluate the role of IL-34 in immunotherapeutic resistance
por: Han, Nanumi, et al.
Publicado: (2021)

A mechanism of IL-34-induced resistance against cytotoxic anti-cancer therapies such as radiation by X-ray and chemotherapy by Oxaliplatin
por: Han, Nanumi, et al.
Publicado: (2023)

Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
por: Han, Nanumi, et al.
Publicado: (2018)

Enhanced expression of IL-34 in an inflammatory cyst of the submandibular gland: a case report
por: Baghdadi, Muhammad, et al.
Publicado: (2018)

Efficient generation of thymic epithelium from induced pluripotent stem cells that prolongs allograft survival
por: Otsuka, Ryo, et al.
Publicado: (2020)

Author Correction: Efficient generation of thymic epithelium from induced pluripotent stem cells that prolongs allograft survival
por: Otsuka, Ryo, et al.
Publicado: (2021)

Immune reaction and regulation in transplantation based on pluripotent stem cell technology
por: Otsuka, Ryo, et al.
Publicado: (2020)

Induction of Macrophage-Like Immunosuppressive Cells from Mouse ES Cells That Contribute to Prolong Allogeneic Graft Survival
por: Kudo, Hiroya, et al.
Publicado: (2014)

Induction of macrophage-like immunosuppressive cells from common marmoset ES cells by stepwise differentiation with DZNep
por: Tsuji, Hyuma, et al.
Publicado: (2020)

Flow cytometric identification and cell-line establishment of macrophages in naked mole-rats
por: Wada, Haruka, et al.
Publicado: (2019)

Tumor cell-induced macrophage senescence plays a pivotal role in tumor initiation followed by stable growth in immunocompetent condition
por: Wada, Haruka, et al.
Publicado: (2023)

High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers
por: Baghdadi, Muhammad, et al.
Publicado: (2018)

Macrophage activation syndrome and COVID-19
por: Otsuka, Ryo, et al.
Publicado: (2020)

Establishment of an experimental model for MHC homo-to-hetero transplantation
por: Murata, Tomoki, et al.
Publicado: (2020)

Evaluation of immunosuppression protocols for MHC-matched allogeneic iPS cell-based transplantation using a mouse skin transplantation model
por: Kamatani, Tomoki, et al.
Publicado: (2022)

Functional networks of the human bromodomain-containing proteins
por: Gao, Cong, et al.
Publicado: (2022)

Establishment of Human Leukocyte Antigen-Mismatched Immune Responses after Transplantation of Human Liver Bud in Humanized Mouse Models
por: Mori, Akihiro, et al.
Publicado: (2021)

Clinical significance of side population in ovarian cancer cells
por: Hosonuma, Shinji, et al.
Publicado: (2011)

Drug Discovery Targeting Bromodomain-Containing Protein 4
por: Liu, Zhiqing, et al.
Publicado: (2017)

Bromodomain-Containing Protein BRD4 Is Hyperphosphorylated in Mitosis
por: Wang, Ranran, et al.
Publicado: (2020)

Augmented interferon regulatory factor 7 axis in whole tumor cell vaccines prevents tumor recurrence by inducing interferon gamma-secreting B cells
por: Kajihara, Nabeel, et al.
Publicado: (2023)

Selectivity Mechanism of Pyrrolopyridone Analogues Targeting Bromodomain 2 of Bromodomain-Containing Protein 4 from Molecular Dynamics Simulations
por: Shi, Mingsong, et al.
Publicado: (2023)

Features of Cryptic Promoters and Their Varied Reliance on Bromodomain-Containing Factors
por: Pattenden, Samantha G., et al.
Publicado: (2010)

Targeting bromodomain-containing proteins: research advances of drug discovery
por: Pan, Zhaoping, et al.
Publicado: (2023)

Potential anti-lymphoma effect of M-CSFR inhibitor in adult T-cell leukemia/lymphoma
por: Komohara, Yoshihiro, et al.
Publicado: (2018)

Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors
por: Flynn, Noah R., et al.
Publicado: (2021)

Bromodomain-containing factor GTE4 regulates Arabidopsis immune response
por: Zhou, Qin, et al.
Publicado: (2022)

Development of neurodevelopmental disorders: a regulatory mechanism involving bromodomain-containing proteins
por: Li, Junlin, et al.
Publicado: (2013)

USP24 stabilizes bromodomain containing proteins to promote lung cancer malignancy
por: Wang, Shao-An, et al.
Publicado: (2020)

Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer
por: Cheng, Carol Lai-Hung, et al.
Publicado: (2021)

Bromodomains as therapeutic targets
por: Muller, Susanne, et al.
Publicado: (2011)

Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast Differentiation
por: Meier, Julia C., et al.
Publicado: (2017)

Role of Interleukin-34 in Cancer
por: Franzè, Eleonora, et al.
Publicado: (2020)

Applying (89)Zr-Transferrin To Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins
por: Doran, Michael G., et al.
Publicado: (2016)

Histone Deacetylase Inhibitors (HDACi) Cause the Selective Depletion of Bromodomain Containing Proteins (BCPs)
por: Mackmull, Marie-Therese, et al.
Publicado: (2015)

Selective Inhibition of Bromodomain-Containing Protein 4 Reduces Myofibroblast Transdifferentiation and Pulmonary Fibrosis
por: Bernau, Ksenija, et al.
Publicado: (2022)

The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma
por: Yang, Qiwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9h8to0q3uf2sjj7c2t7k113uii